The Waiting Time of Prostate Cancer Patients in Poland
Abstract
:1. Introduction
2. Materials and Methods
Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Kalbarczyk, W.P.; Gujski, M.; Brzozowski, S.; Tytko, Z. Walka z nowotworami i opieka onkologiczna w Polsce wobec wyzwań demograficznych i epidemiologicznych—Propozycje rozwiązań; Instytut Ochrony Zdrowia: Warszawa, Poland, 2015. [Google Scholar]
- Didkowska, J.W.U.; Olasek, P. Nowotwory złośliwe w Polsce w 2015 roku; Centrum Onkologii–Instytut im. M. Skłodowskiej–Curie: Warszawa, Poland, 2017. [Google Scholar]
- De Angelis, R.; Sant, M.; Coleman, M.P.; Francisci, S.; Baili, P.; Pierannunzio, D.; Trama, A.; Visser, O.; Brenner, H.; Ardanaz, E.; et al. Cancer survival in Europe 1999–2007 by country and age: Results of EUROCARE–5—A Population-based study. Lancet Oncol. 2014, 15, 23–34. [Google Scholar] [CrossRef]
- EUROCARE Survival of Cancer Patients in Europe: Eurocare 5 Survival Analysis 2000–2007. Available online: https://w3.iss.it/site/EU5Results/forms/SA0007.aspx (accessed on 1 October 2018).
- Buchholz, T.A.; Austin-Seymour, M.M.; Moe, R.E.; Ellis, G.K.; Livingston, R.B.; Pelton, J.G.; Griffin, T.W. Effect of delay in radiation in the combined modality treatment of breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 1993, 26, 23–35. [Google Scholar] [CrossRef]
- Chen, Z.; King, W.; Pearcey, R.; Kerba, M.; Mackillop, W.J. The relationship between waiting time for radiotherapy and clinical outcomes: A systematic review of the literature. Radiother. Oncol. 2008, 87, 3–16. [Google Scholar] [CrossRef] [PubMed]
- Choan, E.; Dahrouge, S.; Samant, R.; Mirzaei, A.; Price, J. Radical radiotherapy for cervix cancer: The effect of waiting time on outcome. Int. J. Radiat. Oncol. Biol. Phys. 2005, 61, 1071–1077. [Google Scholar]
- Montella, M.; Crispo, A.; Botti, G.; De Marco, M.; de Bellis, G.; Fabbrocini, G.; Pizzorusso, M.; Tamburini, M.; D’Aiuto, G. An assessment of delays in obtaining definitive breast cancer treatment in Southern Italy. Breast Cancer Res Treat. 2001, 66, 209–215. [Google Scholar] [CrossRef] [PubMed]
- Murray, N.; Coy, P.; Pater, J.L.; Hodson, I.; Arnold, A.; Zee, B.C.; Payne, D.; Kostashuk, E.C.; Evans, W.K.; Dixon, P.; et al. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. J. Clin. Oncol. 1993, 11, 336–344. [Google Scholar] [CrossRef] [PubMed]
- Richards, M.A.; Westcombe, A.M.; Love, S.B.; Littlejohns, P.; Ramirez, A.J. Influence of delay on survival in patients with breast cancer: A systematic review. Lancet 1999, 353, 1119–1126. [Google Scholar] [CrossRef]
- van Harten, M.C.; Hoebers, F.J.; Kross, K.W.; van Werkhoven, E.D.; van den Brekel, M.W.; van Dijk, B.A. Determinants of treatment waiting times for head and neck cancer in the Netherlands and their relation to survival. Oral Oncol. 2015, 51, 272–278. [Google Scholar] [CrossRef] [PubMed]
- Osowiecka, K.; Rucinska, M.; Nowakowski, J.J.; Nawrocki, S. How Long Are Cancer Patients Waiting for Oncological Therapy in Poland? Int. J. Environ. Res. Public Health 2018, 15, 577. [Google Scholar] [CrossRef] [PubMed]
- Dale, W.; Bilir, P.; Han, M.; Meltzer, D. The role of anxiety in prostate carcinoma: A structured review of the literature. Cancer 2005, 104, 467–478. [Google Scholar] [CrossRef] [PubMed]
- Hansen, R.P.; Vedsted, P.; Sokolowski, I.; Sondergaard, J.; Olesen, F. Time intervals from first symptom to treatment of cancer: A cohort study of 2,212 newly diagnosed cancer patients. BMC Health Serv. Res. 2011, 11, 284. [Google Scholar] [CrossRef] [PubMed]
- Helsper, C.C.W.; van Erp, N.N.F.; Peeters, P.; de Wit, N.N.J. Time to diagnosis and treatment for cancer patients in the Netherlands: Room for improvement? Eur. J. Cancer 2017, 87, 113–121. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Stevens, C.; Bondy, S.J.; Loblaw, D.A. Wait times in prostate cancer diagnosis and radiation treatment. Can. Urol. Assoc. J. 2010, 4, 243–248. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Subramonian, K.R.; Puranik, S.; Mufti, G.R. How will the two-weeks-wait rule affect delays in management of urological cancers? J. R. Soc. Med. 2003, 96, 398–399. [Google Scholar] [CrossRef] [PubMed]
- Redaniel, M.T.; Martin, R.M.; Gillatt, D.; Wade, J.; Jeffreys, M. Time from diagnosis to surgery and prostate cancer survival: A retrospective cohort study. BMC Cancer 2013, 13, 559. [Google Scholar] [CrossRef] [PubMed]
- Baade, P.D.; Gardiner, R.A.; Ferguson, M.; Youlden, D.R.; Aitken, J.F.; Yaxley, J.; Chambers, S.K. Factors associated with diagnostic and treatment intervals for prostate cancer in Queensland, Australia: A large cohort study. Cancer Causes Control 2012, 23, 625–634. [Google Scholar] [CrossRef] [PubMed]
- Joiner, M.; Kogel, A. Basic Clinical Radiobiology, 4th ed.; Hodder Arnold: London, UK, 2009. [Google Scholar]
- Hayes, J.H.; Barry, M.J. Screening for prostate cancer with the prostate-specific antigen test: A review of current evidence. JAMA 2014, 311, 1143–1149. [Google Scholar] [CrossRef] [PubMed]
- Ilic, D.; Neuberger, M.M.; Djulbegovic, M.; Dahm, P. Screening for prostate cancer. Cochrane Database Syst. Rev. 2013, 319, 1946. [Google Scholar] [CrossRef] [PubMed]
- Albertsen, P.C. Observational studies and the natural history of screen-detected prostate cancer. Curr. Opin. Urol. 2015, 25, 232–237. [Google Scholar] [CrossRef] [PubMed]
Characteristic | Patients Included in | Patients Included in | ||
---|---|---|---|---|
Suspicion-Treatment Analysis | Suspicion-Diagnosis, Diagnosis-Treatment Analysis | |||
n | % | n | % | |
All patients | 123 | 100 | 101 | 100 |
Age (years) | median 65; range 53–87 | |||
Education | ||||
Primary | 28 | 23 | 24 | 24 |
Secondary | 65 | 53 | 52 | 51 |
Higher | 30 | 24 | 25 | 25 |
Place of residence | ||||
City 101,000–500,000 | 40 | 33 | 32 | 32 |
City 50,000–100,000 | 17 | 14 | 14 | 14 |
City <50,0000 | 33 | 27 | 28 | 28 |
Village | 33 | 27 | 27 | 27 |
Professional activity | ||||
Active | 26 | 21 | 24 | 24 |
Unemployed | 3 | 2 | 2 | 2 |
Pensioner | 94 | 76 | 75 | 74 |
Marital status | ||||
Married | 103 | 84 | 84 | 83 |
Single | 10 | 8 | 9 | 9 |
Widower | 10 | 8 | 8 | 8 |
Type of “patient route” starting points | ||||
Symptoms | 76 | 62 | 66 | 65 |
Prevention | 38 | 31 | 32 | 32 |
Follow-up | 9 | 7 | 3 | 3 |
Method of treatment beginning | ||||
Surgery | 26 | 21 | 14 | 14 |
Radiotherapy | 44 | 36 | 35 | 35 |
Chemotherapy | 3 | 2 | 3 | 3 |
Hormonal therapy | 50 | 41 | 49 | 49 |
Treatment intention | ||||
Curative | 109 | 89 | 94 | 93 |
Palliative | 14 | 11 | 7 | 7 |
Private medical services | ||||
Yes | 33 | 27 | 30 | 30 |
No | 70 | 57 | 60 | 59 |
No data | 20 | 16 | 11 | 11 |
Variable Name | Suspicion-Treatment Time (weeks) n = 123 | Suspicion-Diagnosis Time (Weeks) n = 101 | Diagnosis-Treatment Time (Weeks) n = 101 | ||||||
---|---|---|---|---|---|---|---|---|---|
Median | (25–75% IQR) | p-Value | Median | (25–75% IQR) | p-Value | Median | (25–75% IQR) | p-Value | |
All patients | 18.7 | (10.6–26.9) | 7.7 | (4–16.1) | 8.7 | (4.6–14.1) | |||
Age | >0.05 | >0.05 | >0.05 | ||||||
Education | |||||||||
Primary | 18.1 | (11.8–26.0) | 0.86 | 8.4 | (4.7–14.4) | 0.70 | 8.0 | (3.9–12.7) | 0.55 |
Secondary | 19.9 | (9.7–27.3) | 7.0 | (3.4–17.5) | 9.5 | (5.9–15.9) | |||
Higher | 15.8 | (10.7–25.6) | 8.7 | (4.3–12.3) | 7.3 | (4.1–13.0) | |||
Place of residence | |||||||||
City 101,000–500,000 | 14.9 | (7.7–24.7) | 0.003 | 8.7 | (4.1–11.3) | 0.11 | 7.3 | (3.8–12.9) | 0.34 |
City 50,000–100,000 | 25.0 | (20.1–47.4) | 11.5 | (5.3–42.9) | 13.4 | (6.3–16.7) | |||
City <50,000 | 16.4 | (9.1–23.3) | 6.1 | (3.0–9.4) | 7.5 | (4.7–15.1) | |||
Village | 19.9 | (13.1–26.9) | 9.6 | (4.0–21.0) | 9.3 | (4.6–12.9) | |||
Professional activity | |||||||||
Active | 17.3 | (10.4–23.9) | 0.09 | 4.4 | (2.9–10.6) | 0.20 | 9.9 | (6.0–14.5) | 0.63 |
Unemployed | 36.9 | (25.6–58.9) | 17.9 | (6.4–29.4) | 13.3 | (7.4–19.1) | |||
Pensioner | 18.1 | (10.6–26.9) | 8.7 | (4.1–17.4) | 8.4 | (4.0–14.1) | |||
Marital status | |||||||||
Married | 17.1 | (9.7–26.1) | 0.12 | 7.5 | (3.9–17.4) | 0.76 | 7.9 | (4.1–13.8) | 0.28 |
Single | 22.9 | (21.4–40.3) | 9.0 | (4.4–12.7) | 12.3 | (10.6–15.1) | |||
Widower | 19.6 | (15.4–24.3) | 7.9 | (6.3–12.6) | 13.0 | (5.9–15.0) | |||
Type of “patient route” starting points | |||||||||
Symptoms | 21.0 | (11.7–26.8) | 0.36 | 8.9 | (4.3–17.4) | 0.34 | 8.8 | (3.6–14.6) | 0.95 |
Prevention | 14.8 | (9.7–26.9) | 5.9 | (3.3–12.9) | 8.3 | (6.0–13.8) | |||
Follow-up | 14.0 | (13.6–20.1) | 4.0 | (4.0–32.3) | 10.0 | (2.0–16.1) | |||
Method of treatment beginning | |||||||||
Surgery | 13.6 | (7.1–24.0) | 8.3 | (4.1–15.7) | 8.6 | (6.6–12.9) | |||
Radiotherapy | 21.3 | (14.6–27.7) | 0.06 | 8.7 | (4.7–16.1) | 0.78 | 12.7 | (8.7–17.7) | <0.001 |
Chemotherapy | 34.7 | (9.7–47.4) | 32.0 | (1.3–44.7) | 2.7 | (2.7–8.4) | |||
Hormonal therapy | 17.2 | (10.6–24.3) | 6.6 | (3.9–12.7) | 6.3 | (2.9–10.9) | |||
Treatment intention | |||||||||
Curative | 19.1 | (10.6–26.1) | 0.86 | 7.6 | (4.0–16.1) | 0.63 | 8.6 | (4.9–14.1) | 0.80 |
Palliative | 14.5 | (13.6–27.3) | 9.7 | (4.0–21.0) | 10.0 | (3.0–32.7) | |||
Private medical services | |||||||||
Yes | 19.9 | (10.7–28.9) | 0.69 | 4.6 | (3.4–15.7) | 0.15 | 8.5 | (3.0–16.9) | 0.79 |
No | 21.0 | (12.0–27.4) | 9.2 | (4.9–17.5) | 8.6 | (5.4–13.8) |
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Osowiecka, K.; Nawrocki, S.; Kurowicki, M.; Rucinska, M. The Waiting Time of Prostate Cancer Patients in Poland. Int. J. Environ. Res. Public Health 2019, 16, 342. https://doi.org/10.3390/ijerph16030342
Osowiecka K, Nawrocki S, Kurowicki M, Rucinska M. The Waiting Time of Prostate Cancer Patients in Poland. International Journal of Environmental Research and Public Health. 2019; 16(3):342. https://doi.org/10.3390/ijerph16030342
Chicago/Turabian StyleOsowiecka, Karolina, Sergiusz Nawrocki, Marcin Kurowicki, and Monika Rucinska. 2019. "The Waiting Time of Prostate Cancer Patients in Poland" International Journal of Environmental Research and Public Health 16, no. 3: 342. https://doi.org/10.3390/ijerph16030342